Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Idiopathic pulmonary fibrosis: recent milestones in disease management.

Costabel U.

Eur Respir Rev. 2012 Jun 1;21(124):140. doi: 10.1183/09059180.00000712. No abstract available.

2.

Treating idiopathic pulmonary fibrosis: current opportunities and future challenges.

Richeldi L.

Clin Respir J. 2012 Jul;6(3):129-30. doi: 10.1111/j.1752-699X.2012.00303.x. No abstract available.

PMID:
22697263
3.

[Idiopathic pulmonary fibrosis: treatment with pirfenidone].

Cano-Jiménez E.

Arch Bronconeumol. 2012 Oct;48 Suppl 2:16-8. Spanish. No abstract available.

PMID:
23630972
4.

Idiopathic pulmonary fibrosis and pirfenidone.

Collard HR.

Eur Respir J. 2010 Apr;35(4):728-9. doi: 10.1183/09031936.00006610. No abstract available.

5.

FDA panel likes new treatment for idiopathic pulmonary fibrosis.

Morrow T.

Manag Care. 2010 Apr;19(4):53-4. No abstract available.

6.

Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?

Papiris SA, Kagouridis K, Kolilekas L, Triantafillidou C, Tsangaris I, Manali ED.

Eur Respir J. 2012 Sep;40(3):794-5. doi: 10.1183/09031936.00114311. No abstract available.

7.

[Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].

Tokura T, Oku H, Tsukamoto Y.

Nihon Yakurigaku Zasshi. 2009 Aug;134(2):97-104. Japanese. No abstract available.

PMID:
19672005
8.

Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.

Ishii H, Kushima H, Komiya K, Mizunoe S, Kadota J.

Respiration. 2013;86(1):86-7. doi: 10.1159/000348545. Epub 2013 Apr 9. No abstract available.

PMID:
23594834
9.

[Patient treated with pirfenidone].

Valenzuela C.

Arch Bronconeumol. 2012 Oct;48 Suppl 2:19-20. Spanish. No abstract available.

PMID:
23630973
10.

Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.

Hilberg O, Simonsen U, du Bois R, Bendstrup E.

Clin Respir J. 2012 Jul;6(3):131-43. doi: 10.1111/j.1752-699X.2012.00302.x. Review.

PMID:
22697264
11.

Pirfenidone treatment of idiopathic pulmonary fibrosis.

Azuma A.

Ther Adv Respir Dis. 2012 Apr;6(2):107-14. doi: 10.1177/1753465812436663. Epub 2012 Feb 14. Review.

PMID:
22333982
12.

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.

Ryerson CJ, Collard HR.

Thorax. 2014 Sep;69(9):791-2. doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4. No abstract available.

PMID:
24996636
13.

Novel treatments for idiopathic pulmonary fibrosis.

Spagnolo P.

Am J Med. 2015 May;128(5):447-9. doi: 10.1016/j.amjmed.2015.01.003. Epub 2015 Jan 20. No abstract available.

PMID:
25613299
14.

InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.

Kingwell K.

Nat Rev Drug Discov. 2014 Jul;13(7):483-4. doi: 10.1038/nrd4382. No abstract available.

PMID:
24981347
15.

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.

Raghu G, Selman M.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED. No abstract available.

PMID:
25635489
16.

Two therapies now available for idiopathic pulmonary fibrosis.

Morrow T.

Manag Care. 2014 Dec;23(12):47-8. No abstract available.

17.

Therapeutic advances in idiopathic pulmonary fibrosis.

George G, Vaid U, Summer R.

Clin Pharmacol Ther. 2016 Jan;99(1):30-2. doi: 10.1002/cpt.283. Epub 2015 Nov 18. No abstract available.

PMID:
26502087
18.

Pirfenidone for idiopathic pulmonary fibrosis.

Bouros D.

Lancet. 2011 May 21;377(9779):1727-9. doi: 10.1016/S0140-6736(11)60546-1. Epub 2011 May 13. No abstract available.

PMID:
21571363
19.

New guideline on treatment of idiopathic pulmonary fibrosis.

Spagnolo P, Bonella F, Maher TM.

Lancet Respir Med. 2015 Sep;3(9):e31-2. doi: 10.1016/S2213-2600(15)00322-7. No abstract available.

PMID:
26380887
20.

Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.

Loeh B, Drakopanagiotakis F, Bandelli GP, von der Beck D, Tello S, Cordani E, Rizza E, Barrocu L, Markart P, Seeger W, Guenther A, Albera C.

Am J Respir Crit Care Med. 2015 Jan 1;191(1):110-3. doi: 10.1164/rccm.201406-1106LE. No abstract available.

PMID:
25551350

Supplemental Content

Support Center